Table 1.
TRPM2 Function in Human Cancer
Cancer Type | Study System | Activity | Mechanism | References |
---|---|---|---|---|
Breast Cancer | Breast adenocarcinoma cell lines | TRPM2 inhibition reduced cell proliferation TRPM2 inhibition increased cell death after doxorubicin and tamoxifen |
TRPM2 expression in the nucleus was increased in cancer cells TRPM2 inhibition increased DNA damage |
76,77 |
Gastric Cancer | Gastric cancer cell lines | TRPM2 inhibition reduced cell proliferation TRPM2 down-regulation increased cell death after doxorubicin and paclitaxel |
TRPM2 inhibition decreased mitochondrial function, autophagy, bioenergetics, and JNK signaling TRPM2 inhibition increased ROS and apoptosis. |
62 |
Lung Cancer | NSCLC patient samples Human lung cancer cell lines |
Novel long non-coding RNA (TRPM2-AS) widely expressed High expression of TRPM2-AS correlated with larger tumor size, advanced TNM stage, and poor patient survival |
Long non-coding RNA TRPM2-AS was associated with increased proliferation and reduced apoptosis Down regulation of TRPM2-AS reduced cell proliferation and increased apoptosis |
85 |
Human alveolar epithelial adenocarcinoma cells | TRPM2 inhibition reduced cell survival after irradiation | TRPM2 inhibition suppressed the DNA damage response | 90 | |
Neuroblastoma | Neuroblastoma patient samples Human neuroblastoma cell lines Xenografts |
TRPM2 inhibition reduced cell viability, tumor growth in xenografts TRPM2 inhibition increased chemotherapy sensitivity |
TRPM2 inhibition reduced mitochondrial function, autophagy, antioxidant response, bioenergetics, HIF-1/2a, CREB, MCU level and activity TRPM2 inhibition increased ROS levels |
8,12,15,16, 61,69 |
Pancreatic Cancer | Patient samples Pancreatic cancer cell lines | High TRPM2 expression correlated with shorter patient survival | Higher TRPM2 expression promoted increased cell proliferation, migration, and invasion | 66,89 |
Prostate Cancer | Pati ent Tumor Tissue Human prostate cell lines | TRPM2 inhibition reduced cancer cell proliferation | Significant TRPM2 localization in nucleus in cancer cells | 67 |
Long non-coding antisense TRPM2 transcripts (TRPM2-AS) are overexpressed and linked to poor patient outcome | When TRPM2-AS was reduced, a large increase in TRPM2 expression was detected, associated with increased cell apoptosis | 86,87 | ||
Squamous Cell Carcinoma | Human tongue carcinoma samples Tongue carcinoma cell lines |
TRPM2 inhibition reduced tumor viability | TRPM2 inhibition increased apoptosis, reduced tongue cancer cell survival, and inhibited cancer cell migration Significant TRPM2 localization to the nucleus was found in cancer cells |
64,65 |
T-Cell Leukemia | Human leukemia cell lines | TRPM2 had a pro-survival effect and inhibition increased irradiation-induced cell death | TRPM2 inhibition decreased phosphorylation of CAMKII, reduced cells in G2/M cell cycle arrest, blocked inactivation of cdc2, and increased cell death | 84 |